mark.
fwiw, here's another collaborative press release. i've snipped the first two paragraphs:
GENVEC AND FUSO ANNOUNCE CANCER RESEARCH COLLABORATION
ROCKVILLE, Md. and OSAKA, Japan, April 20 /PRNewswire/ -- GenVec, Inc. and Fuso Pharmaceutical Industries, Ltd. (Tokyo and Osaka: 4538) announced today the signing of a collaborative agreement for the research, development and commercialization of gene therapies for the treatment of human cancer.
Under the agreement GenVec will receive product development related milestone payments and R&D funding for up to five years. In addition, at signature, Fuso purchased equity in GenVec. In return, Fuso receives commercialization rights in Japan, and an option for Korea and Taiwan for products developed under the collaboration. GenVec will receive royalties on any such products commercialized by Fuso, and GenVec retains the right to develop and commercialize the products throughout the rest of the world.
pathfinder.com |
